Peptides for Cancer - Single Course
.75 CME CREDITS – $65.00
Recent advances in peptide biology have found multiple peptides capable of exerting therapeutic benefits in the treatment of cancer. This lecture will discuss peptide classes, mechanisms of action and proposed protocols for incorporating peptide therapy in the treatment of cancer patients.
CME
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Age Management Medicine Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives – After attending this program you should be able to:
- Understand the overall use of Peptides in medicine, how they serve as bio regulators and discuss the science, published studies and chemical make-up of Peptides.
- Learn and understand how to clinically use Peptides within the limits of the Law and within the guidelines of State Medical Boards.
- Understand evidence based science behind the clinical use of Peptides for Delta Induced Sleep, Memory Restoration, Brain Health, Cancer, Immune System Dysregulation and Function, Auto Immune Disease, Increase IGF-1 Levels, Increased Telomere Length, Wound Healing and Sexual Enhancement.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
| First | Last | Commercial Interest |
| Rob | Kominiarek | NA |
| Edwin | Lee | NA |
| Luis | Martinez | NA |
| Kathy | O’Neil Smith | NA |
Acknowledgement of Financial Commercial Support
Tailor Made Compounding Pharmacy
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Release Date: January 1, 2019
Expiration Date: January 30, 2021
Complete Peptides Course Objectives:
- Understand the overall use of Peptides in medicine, how they serve as bio regulators and discuss the science, published studies and chemical make-up of Peptides.
- Learn and understand how to clinically use Peptides within the limits of the Law and within the guidelines of State Medical Boards.
- Understand evidence based science behind the clinical use of Peptides for Delta Induced Sleep, Memory Restoration, Brain Health, Cancer, Immune System Dysregulation and Function, Auto Immune Disease, Increase IGF-1 Levels, Increased Telomere Length, Wound Healing and Sexual Enhancement.
SPECIAL OFFER
This course is part of the Peptides complete series. Purchase the complete series for a discount!
COURSE MENU
ACCOUNT MENU
NEED HELP?
Contact onlinecme@agemed.org
FACULTY
- President and Medical Director, Freedom Wellness Integrative Clinic, Ponce, Puerto Rico
- Co-Founder and Vice President, XanoGene Anti Aging, Genomic & Holistic Clinic, Rio Piedras, Puerto Rico
Luis Martínez, M.D., MPH
Dr. Luis Martínez is a Regenerative and Cell Therapy specialist, clinical researcher and biomedical consultant. He earned his medical degree at The Ponce School of Medicine and completed his residency training at the prestigious University of Pennsylvania. He also completed an Advanced Training Course in Stem Cells in Cancer at the Ponce Health Sciences University/Magee Research Institute consortium. He is board certified in Clinical Lipidology. Dr. Martinez holds a Masters of Public Health with a concentration in Epidemiology and is fellowship trained in Biosecurity. He is the president of XanoGene Clinic, which specializes in Regenerative and Age Management Medicine. He also founded and presides over Regenera Global, a multinational corporation specializing in biotech product development, research, and clinical consulting. Dr. Martinez has advised and helped set up various clinics and laboratories in Latin America within the Regenerative Medicine space. He also serves on the advisory board for various biotech companies and professional societies. He is actively involved in educating and training physicians in multiple aspects of Regenerative and Age Management Medicine.